达安基因

- 002030

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013 
达安基因(002030) 利润表
单位:万元
报表日期2023-06-302023-03-312022-12-312022-09-302022-06-30
一、营业总收入53,621.8434,103.811,204,613.50933,581.49667,604.66
营业收入53,621.8434,103.811,204,613.50933,581.49667,604.66
二、营业总成本55,421.0733,165.59519,146.83357,396.24245,773.55
营业成本25,252.8915,088.95327,153.53238,560.46161,127.54
营业税金及附加285.32126.485,828.643,747.622,789.96
销售费用10,247.085,316.9593,951.1947,707.2633,577.38
管理费用9,785.356,161.5033,076.7533,204.9322,940.40
财务费用-5,340.38-1,169.06-11,103.64-8,973.93-1,551.49
研发费用15,190.817,640.7770,240.3643,149.9126,889.76
资产减值损失----------
公允价值变动收益47,996.022,357.428,232.14-3,867.36-1,848.11
投资收益2,009.00-1,310.6827,118.3924,088.9919,265.43
其中:对联营企业和合营企业的投资收益690.06-1,593.8112,935.9813,094.719,281.09
汇兑收益----------
三、营业利润48,910.025,052.30632,925.43587,833.25433,826.98
加:营业外收入149.395.7295.2727.625.06
减:营业外支出328.2165.511,127.05300.11205.58
其中:非流动资产处置损失----------
四、利润总额48,731.204,992.52631,893.65587,560.75433,626.46
减:所得税费用8,891.931,214.7389,137.8395,138.6572,846.13
五、净利润39,839.273,777.79542,755.82492,422.10360,780.33
归属于母公司所有者的净利润40,275.543,656.14541,234.11491,084.35359,456.36
少数股东损益-436.27121.661,521.721,337.751,323.97
六、每股收益
基本每股收益(元/股)0.29000.02613.85653.49912.5612
稀释每股收益(元/股)0.29000.02613.85653.49912.5612
七、其他综合收益40.09-36.96-284.15292.76108.11
八、综合收益总额39,879.373,740.83542,471.68492,714.86360,888.45
归属于母公司所有者的综合收益总额40,294.793,630.29540,899.26491,321.45359,543.34
归属于少数股东的综合收益总额-415.43110.541,572.421,393.411,345.11
下载全部历史数据到excel中 返回页顶